INC Research Advocates for New Approaches to Sponsor-CRO Alliances at Partnerships in Clinical Trials 2010

New White Paper and Speaker Line-up Provide Insight into How Sponsors Can Enhance Outsourcing Relationships

Orlando, Partnerships in Clinical Trials 2010, Apr. 8, 2010 – INC Research®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, will be speaking at the Partnerships in Clinical Trials conference and prompting drug development companies and CROs to think differently about traditional clinical trial models.

The company recently released a new white paper, “A New Approach to Outsourced Drug Development: How Sponsor-CRO Clinical Delivery Alliances Improve Performance” that outlines how these high-level business partnerships modify the conventional incentive structures for conducting multi-drug development programs. The paper can be downloaded from the site at www.incresearch.com/alliances and will be available at INC Research’s booth #319.

Clinical delivery alliances differ from traditional CRO partnerships largely because incentives are realigned around milestone-based payments, risk sharing or even co-investment in assets. With long-term, multi-drug partnerships, CROs assume responsibility for complete testing of one or all compounds in the pipeline, management of a therapeutic area or specific areas of the drug development process. The paper provides an overview of alliance methodology, outlines the benefits of these partnerships and what sponsors should look for in a CRO when evaluating clinical delivery alliances.

INC Research will also be featuring two speakers at the conference. Jeff Kueffer, VP, Global Operations Management, will be presenting “Project Impact: Ensuring Business Continues to Operate in Difficult Economic Times” on Apr. 13 at 2:30 p.m. Todd Esporas, executive director, Contracts and Functional Services, is a presenter on the “Achieving Compliance by Reconfiguring Payment and Contracting Strategies in Light of Fair Market Value (FMV)” panel on Apr. 13 at 4:45 p.m.

About INC Research® Inc.
INC Research is a therapeutically focused contract research organization with a high performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in therapeutic areas of specialty, and in innovative pediatric and women’s health trials. The company’s The Trusted Process® methodology and therapeutic foresight leads customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, NC. For more information please visit www.incresearch.com.

###